158 related articles for article (PubMed ID: 29089233)
1. Potential anti-proliferative agents from 1,4-benzoxazinone-quinazolin-4(3H)-one templates.
Bollu R; Banu S; Kasaboina S; Bantu R; Nagarapu L; Polepalli S; Jain N
Bioorg Med Chem Lett; 2017 Dec; 27(24):5481-5484. PubMed ID: 29089233
[TBL] [Abstract][Full Text] [Related]
2. Rational design, synthesis and anti-proliferative evaluation of novel 1,4-benzoxazine-[1,2,3]triazole hybrids.
Bollu R; Palem JD; Bantu R; Guguloth V; Nagarapu L; Polepalli S; Jain N
Eur J Med Chem; 2015 Jan; 89():138-46. PubMed ID: 25462234
[TBL] [Abstract][Full Text] [Related]
3. Quinazolinones-Phenylquinoxaline hybrids with unsaturation/saturation linkers as novel anti-proliferative agents.
Palem JD; Alugubelli GR; Bantu R; Nagarapu L; Polepalli S; Jain SN; Bathini R; Manga V
Bioorg Med Chem Lett; 2016 Jul; 26(13):3014-3018. PubMed ID: 27209232
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antitumor evaluation of trimethoxyanilides based on 4(3H)-quinazolinone scaffolds.
Mohamed MA; Ayyad RR; Shawer TZ; Abdel-Aziz AA; El-Azab AS
Eur J Med Chem; 2016 Apr; 112():106-113. PubMed ID: 26890117
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antitumor activity of some 2, 3-disubstituted quinazolin-4(3H)-ones and 4, 6- disubstituted- 1, 2, 3, 4-tetrahydroquinazolin-2H-ones.
Abdel Gawad NM; Georgey HH; Youssef RM; El-Sayed NA
Eur J Med Chem; 2010 Dec; 45(12):6058-67. PubMed ID: 21051122
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of quinazolin-4(3H)-one derivatives bearing dithiocarbamate side chain at C2-position as potential antitumor agents.
Ding PP; Gao M; Mao BB; Cao SL; Liu CH; Yang CR; Li ZF; Liao J; Zhao H; Li Z; Li J; Wang H; Xu X
Eur J Med Chem; 2016 Jan; 108():364-373. PubMed ID: 26703795
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and anticancer activity of N-substituted 2-arylquinazolinones bearing trans-stilbene scaffold.
Mahdavi M; Pedrood K; Safavi M; Saeedi M; Pordeli M; Ardestani SK; Emami S; Adib M; Foroumadi A; Shafiee A
Eur J Med Chem; 2015 May; 95():492-9. PubMed ID: 25847767
[TBL] [Abstract][Full Text] [Related]
8. Lemon Juice Mediated Synthesis of 3-Substituted Quinazolin-4(3H)-Ones and their Pharmacological Evaluation.
Prasad MG; Lakshmi CV; Katari NK; Jonnalagadda SB; Pal M
Anticancer Agents Med Chem; 2019; 19(16):2001-2009. PubMed ID: 31340741
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and
Le Y; Gan Y; Fu Y; Liu J; Li W; Zou X; Zhou Z; Wang Z; Ouyang G; Yan L
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):555-564. PubMed ID: 31967481
[TBL] [Abstract][Full Text] [Related]
10. Novel quinazolin-4(3H)-one/Schiff base hybrids as antiproliferative and phosphodiesterase 4 inhibitors: design, synthesis, and docking studies.
Abdel-Rahman HM; Abdel-Aziz M; Canzoneri JC; Gary BD; Piazza GA
Arch Pharm (Weinheim); 2014 Sep; 347(9):650-7. PubMed ID: 24985336
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and biological evaluation of novel 3-substituted imidazo[1,2-a]pyridine and quinazolin-4(3H)-one derivatives as PI3Kα inhibitors.
Fan YH; Li W; Liu DD; Bai MX; Song HR; Xu YN; Lee S; Zhou ZP; Wang J; Ding HW
Eur J Med Chem; 2017 Oct; 139():95-106. PubMed ID: 28800461
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and cytotoxic evaluation of quinazolin-4(3H)-one derivatives bearing thiocarbamate, thiourea or N-methyldithiocarbamate side chains.
Cao SL; Xu H; Wang Y; Liao J; Zhang JJ; Li ZF; Guo YW; Li XR; Cui XM; Xu X
Med Chem; 2012 Mar; 8(2):163-73. PubMed ID: 22385175
[TBL] [Abstract][Full Text] [Related]
13. Parallel solution phase synthesis of 3,6,7-4(3H)-quinazolinones and evaluation of their antitumor activities against human cancer.
Wu H; Xie X; Liu G
J Comb Chem; 2010 May; 12(3):346-55. PubMed ID: 20196566
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, in vitro antitumour activity, and molecular docking study of novel 2-substituted mercapto-3-(3,4,5-trimethoxybenzyl)-4(3H)-quinazolinone analogues.
El-Azab AS; Abdel-Aziz AA; Ghabbour HA; Al-Gendy MA
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1229-1239. PubMed ID: 28948843
[TBL] [Abstract][Full Text] [Related]
15. Design, Synthesis, and Antiproliferative Activity of Quinazolin-4-One/Chalcone Hybrids
Hisham M; Hassan HA; Gomaa HAM; Youssif BGM; Hayalah AM; Abdel-Aziz M
Anticancer Agents Med Chem; 2023; 23(17):1932-1943. PubMed ID: 37497685
[TBL] [Abstract][Full Text] [Related]
16. Novel quinazolin-4(3H)-one linked to 1,2,3-triazoles: Synthesis and anticancer activity.
Safavi M; Ashtari A; Khalili F; Mirfazli SS; Saeedi M; Ardestani SK; Rashidi Ranjbar P; Barazandeh Tehrani M; Larijani B; Mahdavi M
Chem Biol Drug Des; 2018 Jul; 92(1):1373-1381. PubMed ID: 29637699
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological evaluation of novel 6-(pyridin-3-yl) quinazolin-4(3H)-one derivatives as potential anticancer agents via PI3K inhibition.
Yang H; Li Q; Su M; Luo F; Liu Y; Wang D; Fan Y
Bioorg Med Chem; 2021 Sep; 46():116346. PubMed ID: 34403956
[TBL] [Abstract][Full Text] [Related]
18. Quinazolin-4(3
Mirgany TO; Abdalla AN; Arifuzzaman M; Motiur Rahman AFM; Al-Salem HS
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):2055-2067. PubMed ID: 34551654
[TBL] [Abstract][Full Text] [Related]
19. Development of certain novel N-(2-(2-(2-oxoindolin-3-ylidene)hydrazinecarbonyl)phenyl)-benzamides and 3-(2-oxoindolin-3-ylideneamino)-2-substituted quinazolin-4(3H)-ones as CFM-1 analogs: design, synthesis, QSAR analysis and anticancer activity.
Alafeefy AM; Ashour AE; Prasad O; Sinha L; Pathak S; Alasmari FA; Rishi AK; Abdel-Aziz HA
Eur J Med Chem; 2015 Mar; 92():191-201. PubMed ID: 25555142
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and evaluation of new quinazolin-4-one derivatives as apoptotic enhancers and autophagy inhibitors with potent antitumor activity.
ElZahabi HSA; Nafie MS; Osman D; Elghazawy NH; Soliman DH; El-Helby AAH; Arafa RK
Eur J Med Chem; 2021 Oct; 222():113609. PubMed ID: 34119830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
